Insider Trading activities of Illumina Inc insiders. , Part 6

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Illumina Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Illumina Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Illumina Inc since 2005. The reporting company's ticker symbol is ILMN. The reporting company's CIK number is 1110803.
The total value of stock buying since 2005 is $251,823.
The total value of stock sales since 2005 is $987,756,962.
The total value of stock option exercises since 2005 is $178,653,101.



Table 2. Detailed insider stock purchases, sales, and option exercises of Illumina Inc insiders (ILMN) , Part 6
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-10-31 Bouchard Michel (VP, Finance) Option Ex 787 37.04 29,150
2013-10-30 Henry Christian O (Sr VP, General Manager Genomic) Sale 6,000 93.55 561,306
2013-10-30 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 6,000 28.45 170,700
2013-10-30 Walt David R (Director) Sale 5,000 93.38 466,915
2013-10-28 Rastetter William H (Director) Sale 20,000 92.59 1,851,800
2013-10-28 Rastetter William H (Director) Option Ex 20,000 3.24 64,800
2013-10-24 Flatley Jay T (President & CEO) Sale 30,000 92.27 2,768,010
2013-10-24 Flatley Jay T (President & CEO) Option Ex 30,000 10.48 314,550
2013-10-22 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 20,000 90.00 1,800,000
2013-10-22 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 20,000 69.34 1,386,800
2013-10-17 Heath Gregory (Sr VP & General Manager) Sale 1,875 82.09 153,918
2013-10-17 Heath Gregory (Sr VP & General Manager) Option Ex 1,875 53.19 99,731
2013-10-16 Walt David R (Director) Sale 5,000 82.91 414,560
2013-10-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 4,000 81.32 325,264
2013-10-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 4,000 43.37 173,480
2013-10-10 Henry Christian O (Sr VP, General Manager Genomic) Sale 6,000 77.51 465,042
2013-10-10 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 6,000 28.45 170,700
2013-10-10 Flatley Jay T (President & CEO) Sale 20,000 77.73 1,554,600
2013-10-10 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-10-02 Walt David R (Director) Sale 5,000 80.58 402,885
2013-10-01 Bouchard Michel (VP, Finance) Sale 788 81.05 63,867
2013-10-01 Bouchard Michel (VP, Finance) Option Ex 788 37.04 29,187
2013-09-26 Henry Christian O (Sr VP, General Manager Genomic) Sale 6,000 81.34 488,027
2013-09-26 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 6,000 28.45 170,700
2013-09-26 Flatley Jay T (President & CEO) Sale 20,000 81.34 1,626,740
2013-09-26 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-09-18 Walt David R (Director) Sale 5,000 83.33 416,665
2013-09-17 Heath Gregory (Sr VP & General Manager) Sale 1,875 85.20 159,750
2013-09-17 Heath Gregory (Sr VP & General Manager) Option Ex 1,875 53.19 99,731
2013-09-16 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 4,000 85.00 340,000
2013-09-16 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 4,000 43.37 173,480
2013-09-16 Flatley Jay T (President & CEO) Sale 10,000 85.00 850,000
2013-09-16 Flatley Jay T (President & CEO) Option Ex 10,000 10.48 104,850
2013-09-12 Flatley Jay T (President & CEO) Sale 20,000 82.64 1,652,880
2013-09-12 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-09-10 Heath Gregory (Sr VP & General Manager) Sale 1,875 82.00 153,750
2013-09-10 Heath Gregory (Sr VP & General Manager) Option Ex 1,875 53.19 99,731
2013-09-09 Bianchi Paul L (Sr VP, Human Resources) Sale 1,627 79.03 128,581
2013-09-05 Henry Christian O (Sr VP, General Manager Genomic) Sale 9,000 78.13 703,161
2013-09-05 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 9,000 30.47 274,212
2013-09-04 Walt David R (Director) Sale 5,000 77.19 385,955
2013-09-03 Bouchard Michel (VP, Finance) Sale 787 78.49 61,771
2013-09-03 Bouchard Michel (VP, Finance) Option Ex 787 37.04 29,150
2013-09-03 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 59,000 77.79 4,589,787
2013-09-03 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 59,000 43.37 2,558,830
2013-09-03 Whitfield Roy A (Director) Sale 2,000 78.49 156,980
2013-09-03 Whitfield Roy A (Director) Option Ex 2,000 19.61 39,220
2013-08-30 Lewis Mark L (Sr VP & General Manager) Sale 5,000 78.12 390,590
2013-08-30 Lewis Mark L (Sr VP & General Manager) Option Ex 5,000 37.04 185,200
2013-08-22 Flatley Jay T (President & CEO) Sale 20,000 78.65 1,573,020
2013-08-22 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-08-21 Walt David R (Director) Sale 5,000 78.34 391,715
2013-08-15 Naclerio Nicholas (SVP Corporate Development) Sale 2,000 78.43 156,860
2013-08-15 Naclerio Nicholas (SVP Corporate Development) Option Ex 2,000 43.37 86,740
2013-08-15 Henry Christian O (SVP/GM Genomic Solutions) Sale 9,000 78.23 704,043
2013-08-15 Henry Christian O (SVP/GM Genomic Solutions) Option Ex 9,000 30.47 274,212
2013-08-08 Flatley Jay T (President & CEO) Sale 20,000 78.29 1,565,880
2013-08-08 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-08-07 Walt David R (Director) Sale 5,000 78.47 392,360
2013-08-02 Bouchard Michel (VP, Finance) Sale 151 79.94 12,070
2013-07-31 Bouchard Michel (VP, Finance) Sale 11,314 80.64 912,406
2013-07-31 Bouchard Michel (VP, Finance) Option Ex 11,314 37.04 419,070
2013-07-25 Henry Christian O (Sr VP, General Manager Genomic) Sale 11,462 80.89 927,172
2013-07-25 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 6,000 30.47 182,808
2013-07-25 Flatley Jay T (President & CEO) Sale 20,000 81.30 1,625,920
2013-07-25 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-07-24 Bouchard Michel (VP, Finance) Sale 9,789 79.28 776,042
2013-07-24 Bouchard Michel (VP, Finance) Option Ex 9,789 37.16 363,808
2013-07-24 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 20,000 80.00 1,600,000
2013-07-24 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 20,000 43.37 867,400
2013-07-24 Heath Gregory (Sr VP & General Manager) Sale 209,533 82.00 17,181,706
2013-07-24 Heath Gregory (Sr VP & General Manager) Option Ex 209,533 41.89 8,777,756
2013-07-24 Walt David R (Director) Sale 4,600 81.47 374,785
2013-07-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 2,000 74.50 149,000
2013-07-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 2,000 43.37 86,740
2013-07-11 Ronaghi Mostafa (Sr VP & CTO) Sale 24,000 75.00 1,799,976
2013-07-11 Ronaghi Mostafa (Sr VP & CTO) Option Ex 24,000 36.62 878,951
2013-07-11 Flatley Jay T (President & CEO) Sale 20,000 74.90 1,497,980
2013-07-11 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-07-10 Bouchard Michel (VP, Finance) Sale 3,618 74.30 268,824
2013-07-10 Bouchard Michel (VP, Finance) Option Ex 3,618 37.10 134,235
2013-07-10 Walt David R (Director) Sale 5,000 74.26 371,300
2013-07-09 Henry Christian O (Sr VP, General Manager Genomic) Sale 9,000 74.01 666,054
2013-07-09 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 9,000 30.47 274,212
2013-07-09 Orpin Tristan (Sr VP & Chief Commercial Offic) Sale 6,667 74.19 494,624
2013-07-09 Orpin Tristan (Sr VP & Chief Commercial Offic) Option Ex 6,667 28.45 189,676
2013-06-27 Flatley Jay T (President & CEO) Sale 20,000 74.96 1,499,139
2013-06-27 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-06-26 Bouchard Michel (VP, Finance) Sale 4,272 75.08 320,741
2013-06-26 Bouchard Michel (VP, Finance) Option Ex 4,272 37.12 158,589
2013-06-26 Walt David R (Director) Sale 5,000 75.66 378,295
2013-06-25 Orpin Tristan (Sr VP & Chief Commercial Offic) Sale 35,000 71.98 2,519,300
2013-06-25 Orpin Tristan (Sr VP & Chief Commercial Offic) Option Ex 35,000 28.45 995,750
2013-06-17 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 2,000 68.56 137,120
2013-06-17 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 2,000 43.37 86,740
2013-06-14 Henry Christian O (Sr VP, General Manager Genomic) Sale 25,959 68.10 1,767,911
2013-06-14 Henry Christian O (Sr VP, General Manager Genomic) Option Ex 22,052 19.66 433,498
2013-06-13 Orpin Tristan (Sr VP & Chief Commercial Offic) Sale 47,667 66.55 3,172,238
2013-06-13 Orpin Tristan (Sr VP & Chief Commercial Offic) Option Ex 47,667 19.66 937,037
2013-06-13 Flatley Jay T (President & CEO) Sale 20,000 66.49 1,329,720
2013-06-13 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-06-12 Bouchard Michel (VP, Finance) Sale 5,170 68.63 354,837
2013-06-12 Bouchard Michel (VP, Finance) Option Ex 5,170 37.10 191,817
2013-06-12 Walt David R (Director) Sale 5,000 67.79 338,965
2013-06-11 Ronaghi Mostafa (Sr VP & CTO) Sale 24,000 69.14 1,659,240
2013-06-11 Ronaghi Mostafa (Sr VP & CTO) Option Ex 24,000 36.62 878,951
2013-06-03 Eastham Karin (Director) Sale 10,000 70.34 703,379
2013-06-03 Eastham Karin (Director) Option Ex 10,000 13.30 133,000
2013-05-31 Lewis Mark L (Sr VP & General Manager) Sale 13,000 71.82 933,634
2013-05-31 Lewis Mark L (Sr VP & General Manager) Option Ex 13,000 29.20 379,665
2013-05-30 Posard Matthew L. (Sr VP & General Manager) Sale 2,836 70.80 200,788
2013-05-30 Posard Matthew L. (Sr VP & General Manager) Option Ex 2,836 37.04 105,045
2013-05-29 Bouchard Michel (VP, Finance) Sale 6,276 71.00 445,608
2013-05-29 Bouchard Michel (VP, Finance) Option Ex 6,276 37.12 232,983
2013-05-29 Walt David R (Director) Sale 5,000 71.16 355,775
2013-05-23 Flatley Jay T (President & CEO) Sale 20,000 68.72 1,374,460
2013-05-23 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-05-21 Flatley Jay T (President & CEO) Sale 4,000 73.21 292,840
2013-05-20 Stapley Marc (Sr VP & CFO) Sale 2,843 72.86 207,135
2013-05-20 Stapley Marc (Sr VP & CFO) Option Ex 2,843 36.30 103,200
2013-05-15 Bouchard Michel (VP, Finance) Sale 14,241 70.75 1,007,550
2013-05-15 Bouchard Michel (VP, Finance) Option Ex 9,002 34.95 314,664
2013-05-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 2,000 70.72 141,440
2013-05-15 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 2,000 43.37 86,740
2013-05-15 Walt David R (Director) Sale 5,000 71.07 355,370
2013-05-13 Ronaghi Mostafa (Sr VP & CTO) Sale 24,000 69.20 1,660,776
2013-05-13 Ronaghi Mostafa (Sr VP & CTO) Option Ex 24,000 36.62 878,951
2013-05-10 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 25,000 72.50 1,812,500
2013-05-10 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 25,000 43.37 1,084,250
2013-05-10 Orpin Tristan (Sr VP & Chief Commercial Offic) Sale 25,000 69.00 1,725,000
2013-05-10 Orpin Tristan (Sr VP & Chief Commercial Offic) Option Ex 25,000 20.04 501,000
2013-05-09 Flatley Jay T (President & CEO) Sale 20,000 66.62 1,332,500
2013-05-09 Flatley Jay T (President & CEO) Option Ex 20,000 10.48 209,700
2013-05-07 Orpin Tristan (Sr VP & Chief Commercial Offic) Sale 5,000 65.68 328,400
2013-05-07 Orpin Tristan (Sr VP & Chief Commercial Offic) Option Ex 5,000 20.04 100,200
2013-05-01 Walt David R (Director) Sale 5,000 64.15 320,750
2013-04-30 Stapley Marc (Sr VP & CFO) Sale 15,000 65.00 975,000
2013-04-30 Stapley Marc (Sr VP & CFO) Option Ex 15,000 36.30 544,500
2013-04-30 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 10,000 65.00 650,000
2013-04-30 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 10,000 43.37 433,700
2013-04-30 Orpin Tristan (SVP & Chief Commercial Officer) Sale 5,000 65.00 325,000
2013-04-30 Orpin Tristan (SVP & Chief Commercial Officer) Option Ex 5,000 20.04 100,200
2013-04-25 Flatley Jay T (President & CEO) Sale 10,000 62.62 626,150
2013-04-25 Flatley Jay T (President & CEO) Option Ex 10,000 10.48 104,850
2013-04-23 Stapley Marc (Sr VP & CFO) Sale 12,710 60.00 762,600
2013-04-23 Stapley Marc (Sr VP & CFO) Option Ex 10,710 36.30 388,772
2013-04-23 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Sale 2,000 60.00 120,000
2013-04-23 Naclerio Nicholas (Sr VP, Corporate & Venture Dev) Option Ex 2,000 43.37 86,740
2013-04-23 Ronaghi Mostafa (Sr Vice President & CTO) Sale 59,000 60.00 3,540,000
2013-04-23 Ronaghi Mostafa (Sr Vice President & CTO) Option Ex 59,000 36.62 2,160,757

Insider trading activities including stock purchases, stock sales, and option exercises of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Illumina Inc (symbol ILMN, CIK number 1110803) see the Securities and Exchange Commission (SEC) website.